Related Experiment Video
Updated: Aug 9, 2026

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
Published on: January 7, 2019
Infective endocarditis in a Finnish teaching hospital: a study on 326 episodes treated during 1980-2004
M Heiro1, H Helenius, S Mäkilä
1Department of Medicine, Turku University Hospital, Finland. maija.heiro@tyks.fi
Objectives:
To evaluate potential changes of infective endocarditis (IE) in patients treated in a Finnish teaching hospital during the past 25 years.
Patients:
326 episodes of IE in 303 patients treated during 1980-2004 were evaluated for clinical characteristics and their changes over time.
Results:
The mean age of the patients increased with time (from 47.2 to 54.5 years, p = 0.003). Twenty-five (7.7%) episodes were associated with intravenous drug use (IVDU), with a significant increase of these episodes after 1996 (from 0 to 19 (20%), p < 0.001). Viridans streptococci were the most common causative agents of IE during 1980-1994, but after that Staphylococcus aureus was the most common pathogen (p = 0.015). The proportion of IE of the aortic valve decreased during the study (from 30 (49%) to 26 (27%), whereas the proportions of mitral (11 (18%) to 33 (35%) and tricuspid valve IE (0 to 13 (14%) increased correspondingly (p = 0.001). This was mainly due to more patients with IVDU. Chronic dialysis for renal failure as an underlying condition increased over time (from 0 to 7 (7.4%), p = 0.015) but no other predisposing conditions changed. Complications such as neurological manifestations and heart failure did not change in frequency, but the incidence of lung emboli increased (from 0% to 10.5%, p < 0.001); 83% of these emboli occurred in patients with IVDU. The proportion of patients requiring surgical treatment and mortality due to IE did not change.
Conclusions:
During these 25 years, the causative agents, affected valves and complications of IE changed to some degree. These changes were mainly attributed to the increase of IVDU-associated IE. Except for the increase in age, the clinical presentation and outcome in non-addicts remained substantially unchanged.
Insights
Infective endocarditis (IE) patterns shifted over 25 years, driven by increased intravenous drug use (IVDU). While patient age rose, outcomes for non-IVDU patients remained stable, with changes in causative agents and affected valves.
Area of Science:
- Cardiology
- Infectious Diseases
- Epidemiology
Background:
- Infective endocarditis (IE) is a serious infection affecting heart valves.
- Understanding temporal trends in IE is crucial for adapting clinical management and public health strategies.
Purpose of the Study:
- To analyze changes in the clinical characteristics, causative agents, affected valves, and outcomes of infective endocarditis (IE) over a 25-year period.
Main Methods:
- A retrospective evaluation of 326 IE episodes in 303 patients treated between 1980 and 2004.
- Analysis of clinical data, including patient demographics, causative pathogens, valve involvement, predisposing conditions, complications, and treatment outcomes.
Main Results:
- The mean patient age increased significantly. A notable rise in IE associated with intravenous drug use (IVDU) was observed after 1996.
- Staphylococcus aureus became the predominant pathogen, replacing Viridans streptococci. Mitral and tricuspid valve involvement increased, while aortic valve IE decreased, largely due to IVDU.
- The incidence of lung emboli rose significantly, primarily in IVDU patients. However, neurological complications, heart failure, surgical treatment rates, and mortality remained unchanged.
Conclusions:
- Significant shifts in IE epidemiology occurred over 25 years, primarily linked to an increase in IVDU-associated cases.
- Changes in causative agents and valve predilection were observed, with a rise in Staphylococcus aureus and increased involvement of mitral and tricuspid valves.
- Despite evolving clinical features, the overall outcomes and mortality for infective endocarditis remained stable, with non-addicted patient presentations largely unchanged.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis IV: Nursing Management
Endocarditis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis
Myocarditis III: Medical Management
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...